United States · Platforms & data · Investing.com

Novo Nordisk Q3 2026 slides: sales recover, outlook raised on GLP-1 growth

Published by Investing.com · United States 2 h ago

Read the full article on Investing.com Sign in to save

MarketNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.investing.com)

Also worth reading

Oportun Financial (NASDAQ:OPRT) Sets New 12-Month High After Better-Than-Expected Earnings

Big Tech’s $500 billion spending spree leaves a lot less for shareholders

ConocoPhillips Q3 preview: High expectations as upstream focus drives growth

Treasury yields fall after Democrats win House and Senate majorities

Best Stocks Under $5

Binance founder issues chilling warning after record crypto heist